Latest Emergency contraception Stories
WASHINGTON, June 16 /PRNewswire-USNewswire/ -- Tomorrow, the Food and Drug Administration (FDA) will hold a hearing to consider approval of a new drug application for an abortifacient drug, ulipristal acetate, as an emergency contraceptive, or a new "Plan B." (Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO) Jeanne Monahan, Family Research Council's Director for the Center for Human Dignity, released the following...
US health regulatory staff said in documents released on Tuesday that a new, longer-lasting "morning-after" pill to prevent unwanted pregnancy appears to work with no unexpected side effects.
American women who live along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives from Mexican pharmacies because they don't need a prescription and can send a friend to pick up the pills.
Providing emergency contraception to women in advance of need does not reduce pregnancy rates, despite increased use and faster use after unprotected sexual intercourse.
Swedish scientists are touting both the safety and effectiveness of home-based abortion medications for women who are 50 to 63 days pregnant.
MORRISTOWN, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and HRA Pharma today announced an exclusive licensing agreement for Watson to become the commercial partner for ulipristal acetate (UPA), a selective progesterone receptor modulator in the U.S.
The first morning after pill which can be taken up to five days after sex is raising concerns that it could promote promiscuity and trigger a rise in sexually transmitted diseases.
TOKYO, November 2 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, has entered into a definitive distribution agreement with ASKA Pharmaceuticals Co., Ltd.
A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.
The condom is now as popular as the pill for UK women, newest figures say.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.